Northern Trust’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-13,983
Closed -$298K – 4499
2024
Q1
$298K Buy
+13,983
New +$167K ﹤0.01% 3748

Northern Trust's FUSN Position: Q2 2024 in Review

Northern Trust sold out of Fusion Pharmaceuticals (FUSN) in Q2 2024, closing a stake of 13,983 shares — an estimated $298K sold.

Northern Trust first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $298K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Northern Trust reported no remaining Fusion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Northern Trust sold 13,983 Fusion Pharmaceuticals shares in Q2 2024, an estimated $298K.
  • Northern Trust first reported a position in Fusion Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Northern Trust's Fusion Pharmaceuticals position peaked at $298K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.